Chimeric Virus-Like Particles as a Vaccine Candidate for Enterovirus 71
Author Information
Author(s): Wang Bo, Liu Qingwei, Shi Jinping, Cai Yicun, Huang Zhong
Primary Institution: Key laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences
Hypothesis
Can chimeric virus-like particles effectively induce immune responses against multiple genotypes of enterovirus 71?
Conclusion
Chimeric virus-like particles can elicit broadly neutralizing antibody responses and are a promising candidate for an EV71 vaccine.
Supporting Evidence
- Chimeric VLPs displayed common neutralizing epitopes of EV71.
- Chimeric VLPs induced EV71 epitope-specific IgG antibodies in mice.
- Chimeric VLP-immunized sera efficiently neutralized different EV71 strains.
Takeaway
Scientists created a new type of vaccine that helps the body fight off a virus called enterovirus 71, which can make people sick.
Methodology
Chimeric virus-like particles were generated and their immunogenicities were evaluated in mice.
Participant Demographics
Mice were used for the immunogenicity evaluation.
Want to read the original?
Access the complete publication on the publisher's website